Funnel plots for intraoperative blood loss. by Xin Liu (43569)

Subjects:

Bias risk assessments for each RCS study. by Xin Liu (43569)

Subjects:

Summary of results. by Xin Liu (43569)

Subjects:

Changes in average BD, PD, and TP of rhizosphere soil (0–60 cm) under different treatments before and after the experiment. by Hongyi Pan (5706971)

Subjects:

CFSE staining of CD8+ T-cells for proliferation assessment. by Eiman Abdo (20642254)

Subjects:

Effect of CD8+ T-cells coculture and CM on hypoxic and normoxic PANC-1 cells. by Eiman Abdo (20642254)

Subjects:

SD and mean TTC under different weights. by Jianrong Cai (14245136)

Subjects:

Each group’s performance on behavioral tests. by Wenbin Wu (292223)

Subjects:

Improvement effect of lactoferrin and Coenzyme Q10 on body composition of mice with sarcopenia. by Wenbin Wu (292223)

Subjects:

The influence of fluoxetine treatment on <i>P</i>. <i>berghei</i> pathogenesis. by Li Gao (131516)

Changes in symptom scores and signs of dry eye disease and meibomian gland dysfunction after treatment with intensive pulse light and meibomian gland expression (n =  218). by Yongwoo Lee (2265172)

Subjects:

Demonstration of decreased Aβ accumulation by DA-9601 treatment. by Mijung Lee (397790)

Mathematical treatments applied to data to correct stable isotope values for lipid content. by Nathan D. McTigue (10706460)

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

Line graph illustrating mean food intake (in grams) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

Subjects:

Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

Subjects:

Ba/F3 EML4-ALK^mutants exhibit variable dose-response to ABT-199 treatment. by Richard Junior Zapata Dongo (17912565)

Quantification of bacterial adhesion revealed a significant decrease in the adhesion of <i>S. aureus</i>, <i>S. epidermidis</i>, and <i>P. aeruginosa</i> on blotted corneas of mice treated with 0.5% bupivacaine (BUP) combined with topical (TOP) application, following subconjunctival injection (SCI) of CGRP, 24 hours before the final BUP treatment (day 14) and again one hour prior to the final bupivacaine injection on day 15. by Ananya Datta (19932144)

Mean scores, standard deviations, and significance on key measures and subscales by gender group. by Silas Manning (22693338)

S8 File - by Martha R. Smith (20410184)

Subjects: